UK announces sh213b in new anti-malaria funding

Simple item page
dc.contributor.authorKwesiga, Pascal
dc.date.accessioned2026-06-22T11:44:44Z
dc.date.available2026-06-22T11:44:44Z
dc.date.issued2017-11-02
dc.descriptionNewspaper Article
dc.description.abstractInside the Rwenzori ballroom of Sheraton Kampala Hotel, four-year-old Leonard Oteng playfully walked around the hall and greeted people as the meeting to announce the end of the second phase of the indoor Residual Spraying (IRS) was getting underway.
dc.identifier.citationKwesiga, P. (2017). UK announces Sh213b in new anti-malaria funding. New Vision.
dc.identifier.urihttps://bdears.busitema.ac.ug/handle/123456789/6364
dc.language.isoen
dc.publisherNew vision
dc.titleUK announces sh213b in new anti-malaria funding
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
NV by Pascal Kwesiga Nov.2.2017.pdf
Size:
905.14 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
Faculty of Health Sciences